{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T10:28:24Z","timestamp":1791196104833,"version":"4.1.0"},"reference-count":103,"publisher":"IMR Press","issue":"7","license":[{"start":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T00:00:00Z","timestamp":1783987200000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82100352"],"award-info":[{"award-number":["82100352"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Tianjin Medical University General Hospital \u201cNew Century Talents\u201d Cultivation Project","award":["XSJ-2021-02"],"award-info":[{"award-number":["XSJ-2021-02"]}]},{"name":"Tianjin Medical University General Hospital Young and Middle-Aged Scientific Research Cultivation Fund","award":["303078100501"],"award-info":[{"award-number":["303078100501"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Rev. Cardiovasc. Med."],"abstract":"<jats:p>While restoring blood flow is the primary treatment for acute myocardial infarction (AMI), this process often triggers additional damage known as myocardial ischemia\/reperfusion injury (MIRI). Recent studies have suggested that regulated cell death is a major contributor to cardiomyocyte injury during ischemia and subsequent reperfusion. Notably, emerging evidence has demonstrated that both ferroptosis and pyroptosis play important roles in the pathogenesis of MIRI. Ferroptosis is primarily driven by iron-dependent lipid peroxidation, whereas pyroptosis is characterized by inflammasome-mediated inflammatory cell death. However, these processes are typically studied independently, and their potential interactions and shared regulatory mechanisms remain unclear. In this review, we comprehensively summarize the molecular mechanisms underlying ferroptosis and pyroptosis in MIRI. We also discuss emerging evidence supporting the crosstalk between these two processes, with a particular focus on shared upstream triggers such as reactive oxygen species (ROS), mitochondrial dysfunction, and common regulatory proteins, including nuclear factor erythroid 2-related factor 2 (Nrf2), p53, and members of the high mobility group box (HMGB) family. Furthermore, we highlight current therapeutic strategies targeting ferroptosis and pyroptosis and explore the potential of dual-targeting approaches based on their shared signaling pathways. A deeper understanding of the interplay between these two forms of cell death may provide novel insights into the pathogenesis of MIRI and support the development of more effective cardioprotective strategies.<\/jats:p>","DOI":"10.31083\/rcm50196","type":"journal-article","created":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T10:31:43Z","timestamp":1785407503000},"source":"Crossref","is-referenced-by-count":1,"title":["Potential Relationship Between Ferroptosis and Pyroptosis in Myocardial Ischemia\/Reperfusion Injury: Molecular Mechanisms and Therapeutic Targets"],"prefix":"10.31083","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-9473-2703","authenticated-orcid":true,"given":"Yuxin","family":"Zhu","sequence":"first","affiliation":[{"name":"Department of Cardiology, Tianjin Medical University General Hospital, 300052 Tianjin, China"},{"name":"The First Clinical College, Tianjin Medical University, 300070 Tianjin, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-9116-5336","authenticated-orcid":true,"given":"Hongmei","family":"Zheng","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Tianjin Medical University General Hospital, 300052 Tianjin, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2358-8244","authenticated-orcid":true,"given":"Hongshi","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Tianjin Medical University General Hospital, 300052 Tianjin, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-9388-1365","authenticated-orcid":true,"given":"Li","family":"Xue","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Tianjin Medical University General Hospital, 300052 Tianjin, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2637-7346","authenticated-orcid":true,"given":"Heng","family":"Cai","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Tianjin Medical University General Hospital, 300052 Tianjin, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6105-2774","authenticated-orcid":true,"given":"Chongzhe","family":"Pei","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Tianjin Medical University General Hospital, 300052 Tianjin, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"16242","published-online":{"date-parts":[[2026,7,14]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","unstructured":"Wang Y, Li Q, Bi L, Wang B, Lv T, Zhang P. Global trends in the burden of ischemic heart disease attributable to smoking from 1990 to 2021: A systematic analysis of the Global Burden of Disease Study 2021. Tobacco Induced Diseases. 2025; 23:  https:\/\/doi.org\/10.18332\/tid\/199931","DOI":"10.18332\/tid\/199931"},{"key":"ref2","doi-asserted-by":"publisher","unstructured":"Qiao G, Lu Y, Wu J, Ren C, Lin R, Zhang C. Progranulin's Protective Mechanisms and Therapeutic Potential in Cardiovascular Disease. Cells. 2025; 14: 762.","DOI":"10.3390\/cells14110762"},{"key":"ref3","doi-asserted-by":"publisher","unstructured":"Xing N, Long XT, Zhang HJ, Fu LD, Huang JY, Chaurembo AI, et al. Research progress on effects of traditional Chinese medicine on myocardial ischemia-reperfusion injury: A review. Frontiers in Pharmacology. 2022; 13: 1055248.","DOI":"10.3389\/fphar.2022.1055248"},{"key":"ref4","doi-asserted-by":"publisher","unstructured":"Qu Z, Pang X, Mei Z, Li Y, Zhang Y, Huang C, et al. The positive feedback loop of the NAT10\/Mybbp1a\/p53 axis promotes cardiomyocyte ferroptosis to exacerbate cardiac I\/R injury. Redox Biology. 2024; 72: 103145.","DOI":"10.1016\/j.redox.2024.103145"},{"key":"ref5","doi-asserted-by":"publisher","unstructured":"Liu Y, Li X, Sun T, Li T, Li Q. Pyroptosis in myocardial ischemia\/reperfusion and its therapeutic implications. European Journal of Pharmacology. 2024; 971: 176464.","DOI":"10.1016\/j.ejphar.2024.176464"},{"key":"ref6","doi-asserted-by":"publisher","unstructured":"Jin B, Zhang Z, Zhang Y, Yang M, Wang C, Xu J, et al. Ferroptosis and myocardial ischemia-reperfusion: mechanistic insights and new therapeutic perspectives. Frontiers in Pharmacology. 2024; 15: 1482986.","DOI":"10.3389\/fphar.2024.1482986"},{"key":"ref7","doi-asserted-by":"publisher","unstructured":"Fan X, Li A, Yan Z, Geng X, Lian L, Lv H, et al. From Iron Metabolism to Ferroptosis: Pathologic Changes in Coronary Heart Disease. Oxidative Medicine and Cellular Longevity. 2022; 2022: 6291889.","DOI":"10.1155\/2022\/6291889"},{"key":"ref8","doi-asserted-by":"publisher","unstructured":"Gunner G, Basu H, Lu Y, Bergstresser M, Sun L, Neel D, et al. Gasdermin D is activated but does not drive neurodegeneration in SOD1G93A model of ALS: Implications for targeting pyroptosis. Neurobiology of Disease. 2025; 214: 107048.","DOI":"10.1016\/j.nbd.2025.107048"},{"key":"ref9","doi-asserted-by":"publisher","unstructured":"Feng F, Luo R, Mu D, Cai Q. Ferroptosis and Pyroptosis in Epilepsy. Molecular Neurobiology. 2024; 61: 7354\u20137368.","DOI":"10.1007\/s12035-024-04018-6"},{"key":"ref10","doi-asserted-by":"publisher","unstructured":"Zhang Z, Yang Z, Wang S, Wang X, Mao J. Ferroptosis and pyroptosis: Mediating mechanisms of the cGAS\/STING pathway and therapeutic strategies in heart failure. Ageing Research Reviews. 2026; 113: 102932.","DOI":"10.1016\/j.arr.2025.102932"},{"key":"ref11","doi-asserted-by":"publisher","unstructured":"Zhao P, Yin S, Qiu Y, Sun C, Yu H. Ferroptosis and pyroptosis are connected through autophagy: a new perspective of overcoming drug resistance. Molecular Cancer. 2025; 24: 23.","DOI":"10.1186\/s12943-024-02217-2"},{"key":"ref12","doi-asserted-by":"publisher","unstructured":"Khawas S, Sharma N. Cell death crosstalk in respiratory diseases: unveiling the relationship between pyroptosis and ferroptosis in asthma and COPD. Molecular and Cellular Biochemistry. 2025; 480: 1305\u20131326.","DOI":"10.1007\/s11010-024-05062-5"},{"key":"ref13","doi-asserted-by":"publisher","unstructured":"He Y, Wang Y, Duan H, Huang D, Jia N, Shen Z, et al. Pharmacological targeting of ferroptosis in hypoxia-induced pulmonary edema: therapeutic potential of ginsenoside Rg3 through activation of the PI3K\/AKT pathway. Frontiers in Pharmacology. 2025; 16: 1644436.","DOI":"10.3389\/fphar.2025.1644436"},{"key":"ref14","doi-asserted-by":"publisher","unstructured":"Nan W, Zhou WM, Zi JL, Shi YQ, Dong YB, Song W, et al. Ferroptosis and bone metabolic diseases: the dual regulatory role of the Nrf2\/HO-1 signaling axis. Frontiers in Cell and Developmental Biology. 2025; 13: 1615197.","DOI":"10.3389\/fcell.2025.1615197"},{"key":"ref15","doi-asserted-by":"publisher","unstructured":"Punchai S, Chaiyagot N, Artkaew N, Jusakul A, Cha'on U, Thanan R, et al. Iron-induced kidney cell damage: insights into molecular mechanisms and potential diagnostic significance of urinary FTL. Frontiers in Molecular Biosciences. 2024; 11: 1352032.","DOI":"10.3389\/fmolb.2024.1352032"},{"key":"ref16","doi-asserted-by":"publisher","unstructured":"Zhou Y, Wang K, Ren M, Wang J, Wang F, Zhuang B, et al. Identification and functional validation of ACSL1 as a biomarker regulating ferroptosis in nucleus pulposus cell. Bioscience Reports. 2025; 45: BSR20241414.","DOI":"10.1042\/BSR20241414"},{"key":"ref17","doi-asserted-by":"publisher","unstructured":"Qin S, Zhu C, Chen C, Sheng Z, Cao Y. An emerging double\u2011edged sword role of ferroptosis in cardiovascular disease (Review). International Journal of Molecular Medicine. 2025; 55: 16.","DOI":"10.3892\/ijmm.2024.5457"},{"key":"ref18","doi-asserted-by":"publisher","unstructured":"Zhang Y, Zheng L, Deng H, Feng D, Hu S, Zhu L, et al. Electroacupuncture Alleviates LPS-Induced ARDS Through \u03b17 Nicotinic Acetylcholine Receptor-Mediated Inhibition of Ferroptosis. Frontiers in Immunology. 2022; 13: 832432.","DOI":"10.3389\/fimmu.2022.832432"},{"key":"ref19","doi-asserted-by":"publisher","unstructured":"Yuan L, Zhao Q, Yan P, Lin J, Qiu X. SOX4 Promotes Ferroptosis to Aggravate Myocardial Ischemia\/Reperfusion Injury Through Elevating DAPK1 Expression. Cardiovascular Toxicology. 2025; 25: 1938\u20131951.","DOI":"10.1007\/s12012-025-10072-w"},{"key":"ref20","doi-asserted-by":"publisher","unstructured":"Cai W, Liu L, Shi X, Liu Y, Wang J, Fang X, et al. Alox15\/15-HpETE Aggravates Myocardial Ischemia-Reperfusion Injury by Promoting Cardiomyocyte Ferroptosis. Circulation. 2023; 147: 1444\u20131460.","DOI":"10.1161\/CIRCULATIONAHA.122.060257"},{"key":"ref21","doi-asserted-by":"publisher","unstructured":"Wang P, Wang D, Lv Z, Zhang P, Su X, Zhao T, et al. Melatonin inhibits ferroptosis in myocardial ischemia\/reperfusion injury by inhibiting the ATM\/p53 signaling pathway. Redox Report : Communications in Free Radical Research. 2025; 30: 2583802.","DOI":"10.1080\/13510002.2025.2583802"},{"key":"ref22","doi-asserted-by":"publisher","unstructured":"Fang X, Ardehali H, Min J, Wang F. The molecular and metabolic landscape of iron and ferroptosis in cardiovascular disease. Nature Reviews. Cardiology. 2023; 20: 7\u201323.","DOI":"10.1038\/s41569-022-00735-4"},{"key":"ref23","doi-asserted-by":"publisher","unstructured":"Tang LJ, Luo XJ, Tu H, Chen H, Xiong XM, Li NS, et al. Ferroptosis occurs in phase of reperfusion but not ischemia in rat heart following ischemia or ischemia\/reperfusion. Naunyn-Schmiedeberg's Archives of Pharmacology. 2021; 394: 401\u2013410.","DOI":"10.1007\/s00210-020-01932-z"},{"key":"ref24","doi-asserted-by":"publisher","unstructured":"Tao Y, Zhou W, Chen C, Zhang Q, Liu Z, Xia P, et al. O-sialoglycoprotein Endopeptidase (OSGEP) Suppresses Hepatic Ischemia-Reperfusion Injury-Induced Ferroptosis Through Modulating the MEK\/ERK Signaling Pathway. Molecular Biotechnology. 2025; 67: 689\u2013704.","DOI":"10.1007\/s12033-024-01084-y"},{"key":"ref25","doi-asserted-by":"publisher","unstructured":"Miyamoto HD, Ikeda M, Ide T, Tadokoro T, Furusawa S, Abe K, et al. Iron Overload via Heme Degradation in the Endoplasmic Reticulum Triggers Ferroptosis in Myocardial Ischemia-Reperfusion Injury. JACC. Basic to Translational Science. 2022; 7: 800\u2013819.","DOI":"10.1016\/j.jacbts.2022.03.012"},{"key":"ref26","doi-asserted-by":"publisher","unstructured":"Zhao L, Cao Y, Liu X, Yang Q, Xu Z. ZIP14 upregulation leads to ferroptosis and lysosomal dysfunction through intracellular iron overload and induces myocardial ischemia\/reperfusion injury in mouse hearts. Journal of Molecular and Cellular Cardiology. 2026; 211: 78\u201391.","DOI":"10.1016\/j.yjmcc.2025.11.014"},{"key":"ref27","doi-asserted-by":"publisher","unstructured":"Lv J, Yin M, Jin H. Hypoxia Aggravates Myocardial Ischemia\/Reperfusion Injury Through the Promotion of Ferroptosis via ACSL4 Lactylation. Journal of Cardiovascular Translational Research. 2025; 18: 1132\u20131145.","DOI":"10.1007\/s12265-025-10671-6"},{"key":"ref28","doi-asserted-by":"publisher","unstructured":"Wang X, Chen T, Chen S, Zhang J, Cai L, Liu C, et al. STING aggravates ferroptosis-dependent myocardial ischemia-reperfusion injury by targeting GPX4 for autophagic degradation. Signal Transduction and Targeted Therapy. 2025; 10: 136.","DOI":"10.1038\/s41392-025-02216-9"},{"key":"ref29","doi-asserted-by":"publisher","unstructured":"Chen B, Fan P, Song X, Duan M. The role and possible mechanism of the ferroptosis-related SLC7A11\/GSH\/GPX4 pathway in myocardial ischemia-reperfusion injury. BMC Cardiovascular Disorders. 2024; 24: 531.","DOI":"10.1186\/s12872-024-04220-3"},{"key":"ref30","doi-asserted-by":"publisher","unstructured":"Zhang M, Zhao Y, Wang X, Yuan Q, Jin H, Tan H, et al. Hyperuricemia exacerbates myocardial ischemia-reperfusion injury by inducing ferroptosis via NCOA4 and xCT-GPX4 axis dysregulation. European Journal of Pharmacology. 2026; 1011: 178424.","DOI":"10.1016\/j.ejphar.2025.178424"},{"key":"ref31","doi-asserted-by":"publisher","unstructured":"Huang Q, Tian H, Tian L, Zhao X, Li L, Zhang Y, et al. Inhibiting Rev-erb\u03b1-mediated ferroptosis alleviates susceptibility to myocardial ischemia-reperfusion injury in type 2 diabetes. Free Radical Biology & Medicine. 2023; 209: 135\u2013150.","DOI":"10.1016\/j.freeradbiomed.2023.09.034"},{"key":"ref32","doi-asserted-by":"publisher","unstructured":"Ekchariyawat P, Saengfak R, Sanongkiet S, Charoenwongpaiboon T, Khongpraphan S, Mala S, et al. ECDD-S16 targets vacuolar ATPase: A potential inhibitor compound for pyroptosis-induced inflammation. PloS One. 2023; 18: e0292340.","DOI":"10.1371\/journal.pone.0292340"},{"key":"ref33","doi-asserted-by":"publisher","unstructured":"Ma M, Jiang W, Zhou R. DAMPs and DAMP-sensing receptors in inflammation and diseases. Immunity. 2024; 57: 752\u2013771.","DOI":"10.1016\/j.immuni.2024.03.002"},{"key":"ref34","doi-asserted-by":"publisher","unstructured":"Tong Y, Wang Z, Cai L, Lin L, Liu J, Cheng J. NLRP3 Inflammasome and Its Central Role in the Cardiovascular Diseases. Oxidative Medicine and Cellular Longevity. 2020; 2020: 4293206.","DOI":"10.1155\/2020\/4293206"},{"key":"ref35","doi-asserted-by":"publisher","unstructured":"Kim MJ, Yoon JH, Ryu JH. Mitophagy: a balance regulator of NLRP3 inflammasome activation. BMB Reports. 2016; 49: 529\u2013535.","DOI":"10.5483\/bmbrep.2016.49.10.115"},{"key":"ref36","doi-asserted-by":"publisher","unstructured":"Saavedra-Torres JS, Pinz\u00f3n-Fern\u00e1ndez MV, Ocampo-Posada M, Nati-Castillo HA, Jim\u00e9nez Hincapie LA, Cadrazo-Gil EJ, et al. Inflammasomes and Signaling Pathways: Key Mechanisms in the Pathophysiology of Sepsis. Cells. 2025; 14: 930.","DOI":"10.3390\/cells14120930"},{"key":"ref37","doi-asserted-by":"publisher","unstructured":"Kim YJ, Choi W, Sim J, Ahn JW, Park J, Kim D, et al. Comparing the Expression of Canonical and Non-Canonical Inflammasomes Across Glioma Grades: Evaluating Their Potential as an Aggressiveness Marker. Brain Tumor Research and Treatment. 2023; 11: 191\u2013203.","DOI":"10.14791\/btrt.2023.0008"},{"key":"ref38","doi-asserted-by":"publisher","unstructured":"Shi J, Zhao Y, Wang K, Shi X, Wang Y, Huang H, et al. Cleavage of GSDMD by inflammatory caspases determines pyroptotic cell death. Nature. 2015; 526: 660\u2013665.","DOI":"10.1038\/nature15514"},{"key":"ref39","doi-asserted-by":"publisher","unstructured":"Long J, Yang SY, Bian ZH, Zhu HX, Ma M, Wang XQ, et al. PD-1+CD8+ T Cell-Mediated Hepatocyte Pyroptosis Promotes Progression of Murine Autoimmune Liver Disease. Advanced Science (Weinheim, Baden-Wurttemberg, Germany). 2025; 12: e2407284.","DOI":"10.1002\/advs.202407284"},{"key":"ref40","doi-asserted-by":"publisher","unstructured":"Zheng F, Yan L, Ren F, Cai W, Lan Y, Chen H, et al. Mechanism of Hypoxia-Induced HMGB1 Regulating NLRP3 Inflammasome\/Caspase-1 Pathway-Mediated Pyroptosis in Myocardial Ischemia Reperfusion Injury Through the Nrf2\/HO-1 Pathway. CNS Neuroscience & Therapeutics. 2025; 31: e70661.","DOI":"10.1111\/cns.70661"},{"key":"ref41","doi-asserted-by":"publisher","unstructured":"Ye X, Hang Y, Lu Y, Li D, Shen F, Guan P, et al. CircRNA circ-NNT mediates myocardial ischemia\/reperfusion injury through activating pyroptosis by sponging miR-33a-5p and regulating USP46 expression. Cell Death Discovery. 2021; 7: 370.","DOI":"10.1038\/s41420-021-00706-7"},{"key":"ref42","doi-asserted-by":"publisher","unstructured":"Zhou W, Yang Y, Feng Z, Zhang Y, Chen Y, Yu T, et al. Inhibition of Caspase-1-dependent pyroptosis alleviates myocardial ischemia\/reperfusion injury during cardiopulmonary bypass (CPB) in type 2 diabetic rats. Scientific Reports. 2024; 14: 19420.","DOI":"10.1038\/s41598-024-70477-5"},{"key":"ref43","doi-asserted-by":"publisher","unstructured":"Zhu Y, Chi J, Cai S, Liu S, Yuan J, Xu H, et al. High-dose remifentanil exacerbates myocardial ischemia-reperfusion injury through activation of calcium-sensing receptor-mediated pyroptosis. International Journal of Medical Sciences. 2023; 20: 1570\u20131583.","DOI":"10.7150\/ijms.83207"},{"key":"ref44","doi-asserted-by":"publisher","unstructured":"Mo G, Liu X, Zhong Y, Mo J, Li Z, Li D, et al. IP3R1 regulates Ca2+ transport and pyroptosis through the NLRP3\/Caspase-1 pathway in myocardial ischemia\/reperfusion injury. Cell Death Discovery. 2021; 7: 31.","DOI":"10.1038\/s41420-021-00404-4"},{"key":"ref45","doi-asserted-by":"publisher","unstructured":"Chen R, Duan J, Zhou Y, Cao M, Su Y, Jiang D, et al. Endothelial HMGB1-AIM2 axis worsens myocardial ischemia-reperfusion injury by regulating endothelial pyroptosis. Apoptosis : an International Journal on Programmed Cell Death. 2025; 30: 2466\u20132479.","DOI":"10.1007\/s10495-025-02162-5"},{"key":"ref46","doi-asserted-by":"publisher","unstructured":"Shen S, He F, Cheng C, Xu B, Sheng J. Uric acid aggravates myocardial ischemia-reperfusion injury via ROS\/NLRP3 pyroptosis pathway. Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie. 2021; 133: 110990.","DOI":"10.1016\/j.biopha.2020.110990"},{"key":"ref47","doi-asserted-by":"publisher","unstructured":"Wang J, Deng B, Liu Q, Huang Y, Chen W, Li J, et al. Pyroptosis and ferroptosis induced by mixed lineage kinase 3 (MLK3) signaling in cardiomyocytes are essential for myocardial fibrosis in response to pressure overload. Cell Death & Disease. 2020; 11: 574.","DOI":"10.1038\/s41419-020-02777-3"},{"key":"ref48","doi-asserted-by":"publisher","unstructured":"Hu X, Zhang H, Zhang Q, Yao X, Ni W, Zhou K. Emerging role of STING signalling in CNS injury: inflammation, autophagy, necroptosis, ferroptosis and pyroptosis. Journal of Neuroinflammation. 2022; 19: 242.","DOI":"10.1186\/s12974-022-02602-y"},{"key":"ref49","doi-asserted-by":"publisher","unstructured":"Xiang Q, Yi X, Zhu XH, Wei X, Jiang DS. Regulated cell death in myocardial ischemia-reperfusion injury. Trends in Endocrinology and Metabolism: TEM. 2024; 35: 219\u2013234.","DOI":"10.1016\/j.tem.2023.10.010"},{"key":"ref50","doi-asserted-by":"publisher","unstructured":"Andrassy M, Volz HC, Igwe JC, Funke B, Eichberger SN, Kaya Z, et al. High-mobility group box-1 in ischemia-reperfusion injury of the heart. Circulation. 2008; 117: 3216\u20133226.","DOI":"10.1161\/CIRCULATIONAHA.108.769331"},{"key":"ref51","doi-asserted-by":"publisher","unstructured":"Sandanger \u00d8, Ranheim T, Vinge LE, Bliks\u00f8en M, Alfsnes K, Finsen AV, et al. The NLRP3 inflammasome is up-regulated in cardiac fibroblasts and mediates myocardial ischaemia-reperfusion injury. Cardiovascular Research. 2013; 99: 164\u2013174.","DOI":"10.1093\/cvr\/cvt091"},{"key":"ref52","doi-asserted-by":"publisher","unstructured":"Kawaguchi M, Takahashi M, Hata T, Kashima Y, Usui F, Morimoto H, et al. Inflammasome activation of cardiac fibroblasts is essential for myocardial ischemia\/reperfusion injury. Circulation. 2011; 123: 594\u2013604.","DOI":"10.1161\/CIRCULATIONAHA.110.982777"},{"key":"ref53","doi-asserted-by":"publisher","unstructured":"Yano T, Abe K, Tanno M, Miki T, Kuno A, Miura T, et al. Does p53 Inhibition Suppress Myocardial Ischemia-Reperfusion Injury? Journal of Cardiovascular Pharmacology and Therapeutics. 2018; 23: 350\u2013357.","DOI":"10.1177\/1074248418763612"},{"key":"ref54","doi-asserted-by":"publisher","unstructured":"Ma XH, Liu JHZ, Liu CY, Sun WY, Duan WJ, Wang G, et al. ALOX15-launched PUFA-phospholipids peroxidation increases the susceptibility of ferroptosis in ischemia-induced myocardial damage. Signal Transduction and Targeted Therapy. 2022; 7: 288.","DOI":"10.1038\/s41392-022-01090-z"},{"key":"ref55","doi-asserted-by":"publisher","unstructured":"Wang X, Wang J, Tu T, Iyan Z, Mungun D, Yang Z, et al. Remote Ischemic Postconditioning Protects against Myocardial Ischemia-Reperfusion Injury by Inhibition of the RAGE-HMGB1 Pathway. BioMed Research International. 2018; 2018: 4565630.","DOI":"10.1155\/2018\/4565630"},{"key":"ref56","doi-asserted-by":"publisher","unstructured":"Zhang H, Liu Y, Cao X, Wang W, Cui X, Yang X, et al. Nrf2 Promotes Inflammation in Early Myocardial Ischemia-Reperfusion via Recruitment and Activation of Macrophages. Frontiers in Immunology. 2021; 12: 763760.","DOI":"10.3389\/fimmu.2021.763760"},{"key":"ref57","doi-asserted-by":"publisher","unstructured":"Feng X, Zhang W, Liu X, Wang Q, Dang X, Han J, et al. Ferroptosis-associated signaling pathways and therapeutic approaches in depression. Frontiers in Neuroscience. 2025; 19: 1559597.","DOI":"10.3389\/fnins.2025.1559597"},{"key":"ref58","doi-asserted-by":"publisher","unstructured":"Cheleschi S, Veronese N, Carta S, Collodel G, Bottaro M, Moretti E, et al. MicroRNA as Possible Mediators of the Synergistic Effect of Celecoxib and Glucosamine Sulfate in Human Osteoarthritic Chondrocyte Exposed to IL-1\u03b2. International Journal of Molecular Sciences. 2023; 24: 14994.","DOI":"10.3390\/ijms241914994"},{"key":"ref59","doi-asserted-by":"publisher","unstructured":"Dong H, Qiang Z, Chai D, Peng J, Xia Y, Hu R, et al. Nrf2 inhibits ferroptosis and protects against acute lung injury due to intestinal ischemia reperfusion via regulating SLC7A11 and HO-1. Aging. 2020; 12: 12943\u201312959.","DOI":"10.18632\/aging.103378"},{"key":"ref60","doi-asserted-by":"publisher","unstructured":"Tian H, Xiong Y, Zhang Y, Leng Y, Tao J, Li L, et al. Activation of NRF2\/FPN1 pathway attenuates myocardial ischemia-reperfusion injury in diabetic rats by regulating iron homeostasis and ferroptosis. Cell Stress & Chaperones. 2021; 27: 149\u2013164.","DOI":"10.1007\/s12192-022-01257-1"},{"key":"ref61","doi-asserted-by":"publisher","unstructured":"Gozzelino R, Jeney V, Soares MP. Mechanisms of cell protection by heme oxygenase-1. Annual Review of Pharmacology and Toxicology. 2010; 50: 323\u2013354.","DOI":"10.1146\/annurev.pharmtox.010909.105600"},{"key":"ref62","doi-asserted-by":"publisher","unstructured":"Han S, Lin F, Qi Y, Liu C, Zhou L, Xia Y, et al. HO-1 Contributes to Luteolin-Triggered Ferroptosis in Clear Cell Renal Cell Carcinoma via Increasing the Labile Iron Pool and Promoting Lipid Peroxidation. Oxidative Medicine and Cellular Longevity. 2022; 2022: 3846217.","DOI":"10.1155\/2022\/3846217"},{"key":"ref63","doi-asserted-by":"publisher","unstructured":"Zi C, Wei Y, Zhu Y, Fan J. RGS12 is a target of penehyclidine hydrochloride that enhances oxidative stress and ferroptosis in a model of myocardial ischemia\/reperfusion injury by inhibiting the Nrf2 pathway. International Journal of Molecular Medicine. 2025; 55: 52.","DOI":"10.3892\/ijmm.2025.5493"},{"key":"ref64","doi-asserted-by":"publisher","unstructured":"Pellegrini L, Foglio E, Pontemezzo E, Germani A, Russo MA, Limana F. HMGB1 and repair: focus on the heart. Pharmacology & Therapeutics. 2019; 196: 160\u2013182.","DOI":"10.1016\/j.pharmthera.2018.12.005"},{"key":"ref65","doi-asserted-by":"publisher","unstructured":"Zhu K, Fan R, Cao Y, Yang W, Zhang Z, Zhou Q, et al. Glycyrrhizin attenuates myocardial ischemia reperfusion injury by suppressing Inflammation, oxidative stress, and ferroptosis via the HMGB1-TLR4-GPX4 pathway. Experimental Cell Research. 2024; 435: 113912.","DOI":"10.1016\/j.yexcr.2024.113912"},{"key":"ref66","doi-asserted-by":"publisher","unstructured":"Wang X, Liang Z, Liu M, Ouyang J, Gao P, Pan G. Non-anticoagulant heparin alleviates myocardial ischemia-reperfusion injury through inhibiting GSDMD-mediated cardiomyocyte pyroptosis via the HMGB1\/RAGE pathway. International Immunopharmacology. 2025; 165: 115412.","DOI":"10.1016\/j.intimp.2025.115412"},{"key":"ref67","doi-asserted-by":"publisher","unstructured":"Starkova T, Polyanichko A, Tomilin AN, Chikhirzhina E. Structure and Functions of HMGB2 Protein. International Journal of Molecular Sciences. 2023; 24: 8334.","DOI":"10.3390\/ijms24098334"},{"key":"ref68","doi-asserted-by":"publisher","unstructured":"Cheng H, Jin A, Zhang Q, Ye S, Zheng Y. KLF9-Mediated Transcriptional Promotion of HMGB2 Accelerates Cardiomyocyte Apoptosis, Inflammation, and Ferroptosis in Myocardial Ischemia\/Reperfusion Injury. Cardiovascular Toxicology. 2025; 25: 1181\u20131190.","DOI":"10.1007\/s12012-025-10028-0"},{"key":"ref69","doi-asserted-by":"publisher","unstructured":"Levine AJ. p53: 800 million years of evolution and 40 years of discovery. Nature Reviews. Cancer. 2020; 20: 471\u2013480.","DOI":"10.1038\/s41568-020-0262-1"},{"key":"ref70","doi-asserted-by":"publisher","unstructured":"Wang SJ, Li D, Ou Y, Jiang L, Chen Y, Zhao Y, et al. Acetylation Is Crucial for p53-Mediated Ferroptosis and Tumor Suppression. Cell Reports. 2016; 17: 366\u2013373.","DOI":"10.1016\/j.celrep.2016.09.022"},{"key":"ref71","doi-asserted-by":"publisher","unstructured":"Gong Y, Yang H, Chen T, Zhang J, Kong B, Shuai W, et al. USP38 exacerbates myocardial injury and malignant ventricular arrhythmias after ischemia\/reperfusion by promoting ferroptosis through the P53\/SLC7A11 pathway. International Immunopharmacology. 2025; 145: 113727.","DOI":"10.1016\/j.intimp.2024.113727"},{"key":"ref72","doi-asserted-by":"publisher","unstructured":"Xie Y, Zhu S, Song X, Sun X, Fan Y, Liu J, et al. The Tumor Suppressor p53 Limits Ferroptosis by Blocking DPP4 Activity. Cell Reports. 2017; 20: 1692\u20131704.","DOI":"10.1016\/j.celrep.2017.07.055"},{"key":"ref73","doi-asserted-by":"publisher","unstructured":"Huang KY, Liu S, Yu YW, Wu BS, Lin ZH, Zhu CX, et al. 3,4-benzopyrene aggravates myocardial ischemia-reperfusion injury-induced pyroptosis through inhibition of autophagy-dependent NLRP3 degradation. Ecotoxicology and Environmental Safety. 2023; 254: 114701.","DOI":"10.1016\/j.ecoenv.2023.114701"},{"key":"ref74","doi-asserted-by":"publisher","unstructured":"Gong G, Wan W, Zhang X, Chen X, Yin J. Management of ROS and Regulatory Cell Death in Myocardial Ischemia-Reperfusion Injury. Molecular Biotechnology. 2025; 67: 1765\u20131783.","DOI":"10.1007\/s12033-024-01173-y"},{"key":"ref75","doi-asserted-by":"publisher","unstructured":"Yu H, Hong X, Liu L, Wu Y, Xie X, Fang G, et al. Cordycepin Decreases Ischemia\/Reperfusion Injury in Diabetic Hearts via Upregulating AMPK\/Mfn2-dependent Mitochondrial Fusion. Frontiers in Pharmacology. 2021; 12: 754005.","DOI":"10.3389\/fphar.2021.754005"},{"key":"ref76","doi-asserted-by":"publisher","unstructured":"Dixon SJ, Lemberg KM, Lamprecht MR, Skouta R, Zaitsev EM, Gleason CE, et al. Ferroptosis: an iron-dependent form of nonapoptotic cell death. Cell. 2012; 149: 1060\u20131072.","DOI":"10.1016\/j.cell.2012.03.042"},{"key":"ref77","doi-asserted-by":"publisher","unstructured":"Zhang AY, Su JB, Sun HT, Liu Q, Li R, Zhang Y, et al. Stachyose ameliorates myocardial ischemia-reperfusion injury by inhibiting cardiomyocyte ferroptosis and macrophage pyroptosis. International Immunopharmacology. 2024; 143: 113334.","DOI":"10.1016\/j.intimp.2024.113334"},{"key":"ref78","doi-asserted-by":"publisher","unstructured":"Tang D, Chen X, Kang R, Kroemer G. Ferroptosis: molecular mechanisms and health implications. Cell Research. 2021; 31: 107\u2013125.","DOI":"10.1038\/s41422-020-00441-1"},{"key":"ref79","doi-asserted-by":"publisher","unstructured":"Deng L, He S, Guo N, Tian W, Zhang W, Luo L. Molecular mechanisms of ferroptosis and relevance to inflammation. Inflammation Research. 2023; 72: 281\u2013299.","DOI":"10.1007\/s00011-022-01672-1"},{"key":"ref80","doi-asserted-by":"publisher","unstructured":"Ishimaru K, Ikeda M, Miyamoto HD, Furusawa S, Abe K, Watanabe M, et al. Deferasirox Targeting Ferroptosis Synergistically Ameliorates Myocardial Ischemia Reperfusion Injury in Conjunction With Cyclosporine A. Journal of the American Heart Association. 2024; 13: e031219.","DOI":"10.1161\/JAHA.123.031219"},{"key":"ref81","doi-asserted-by":"publisher","unstructured":"Zhu M, Zhao T, Zha B, Zhang G, Qian W, Wang X, et al. Piceatannol protects against myocardial ischemia\/reperfusion injury by inhibiting ferroptosis via Nrf-2 signaling-mediated iron metabolism. Biochemical and Biophysical Research Communications. 2024; 700: 149598.","DOI":"10.1016\/j.bbrc.2024.149598"},{"key":"ref82","doi-asserted-by":"publisher","unstructured":"Huang Q, Tian L, Zhang Y, Qiu Z, Lei S, Xia ZY. Nobiletin alleviates myocardial ischemia-reperfusion injury via ferroptosis in rats with type-2 diabetes mellitus. Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie. 2023; 163: 114795.","DOI":"10.1016\/j.biopha.2023.114795"},{"key":"ref83","doi-asserted-by":"publisher","unstructured":"Sun Q, Lv M, Wang Z. Delphinidin inhibits the ALOX15-mediated ferroptosis in rats to alleviate myocardial ischemia and reperfusion injury. Biochimica et Biophysica Acta. Molecular Cell Research. 2025; 1872: 120006.","DOI":"10.1016\/j.bbamcr.2025.120006"},{"key":"ref84","doi-asserted-by":"publisher","unstructured":"Li Y, Chen Y, Yu P, Zhang D, Tang X, Zhu Z, et al. Mild therapeutic hypothermic protection activates the PI3K\/AKT signaling pathway to inhibit TRPM7 and suppress ferroptosis induced by myocardial ischemia\u2011reperfusion injury. Molecular Medicine Reports. 2024; 30: 220.","DOI":"10.3892\/mmr.2024.13345"},{"key":"ref85","doi-asserted-by":"publisher","unstructured":"He M, Yang Y, He X, Lei R, Liu H, Yang M. Melatonin inhibits ferroptosis through the ATF3\/GPX4 signaling pathway to relieve myocardial ischemia-reperfusion injury in rats. In vitro Cellular & Developmental Biology. Animal. 2025; 61: 135\u2013148.","DOI":"10.1007\/s11626-024-00995-z"},{"key":"ref86","doi-asserted-by":"publisher","unstructured":"Wang M, Ren Z, Sun X, Li Y, Chen Z. Dexmedetomidine preconditioning attenuates ferroptosis in myocardial ischemia-reperfusion injury via \u03b12 adrenergic receptor activation. Heliyon. 2024; 10: e39697.","DOI":"10.1016\/j.heliyon.2024.e39697"},{"key":"ref87","doi-asserted-by":"publisher","unstructured":"Yu P, Zhang J, Ding Y, Chen D, Sun H, Yuan F, et al. Dexmedetomidine post-conditioning alleviates myocardial ischemia-reperfusion injury in rats by ferroptosis inhibition via SLC7A11\/GPX4 axis activation. Human Cell. 2022; 35: 836\u2013848.","DOI":"10.1007\/s13577-022-00682-9"},{"key":"ref88","doi-asserted-by":"publisher","unstructured":"Yang K, Kong X, Xie C, Chen Y, Zou Z, Wang X, et al. Combined administration of dexmedetomidine and propofol mitigates myocardial ischemia\/reperfusion injury by modulating the Akt\/mTOR\/Nrf2 axis to suppress ferroptosis. European Journal of Pharmacology. 2025; 997: 177599.","DOI":"10.1016\/j.ejphar.2025.177599"},{"key":"ref89","doi-asserted-by":"publisher","unstructured":"Li X, Sun YX, Tjahjono AW, Wei Y, Li X, Zheng QH, et al. Acupuncture attenuates myocardial ischemia\/reperfusion injury-induced ferroptosis via the Nrf2\/HO-1 pathway. Chinese Medicine. 2025; 20: 61.","DOI":"10.1186\/s13020-025-01114-0"},{"key":"ref90","doi-asserted-by":"publisher","unstructured":"Zhang P, Qin Y, Wang H, Wang J. Vagus nerve stimulation alleviates myocardial injury following hepatic ischemia-reperfusion in rats by inhibiting ferroptosis via the activation of the SLC7A11\/GPX4 axis. European Journal of Medical Research. 2025; 30: 162.","DOI":"10.1186\/s40001-025-02416-7"},{"key":"ref91","doi-asserted-by":"publisher","unstructured":"Wang L, Liu J, Wang Z, Qian X, Zhao Y, Wang Q, et al. Dexmedetomidine abates myocardial ischemia reperfusion injury through inhibition of pyroptosis via regulation of miR-665\/MEF2D\/Nrf2 axis. Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie. 2023; 165: 115255.","DOI":"10.1016\/j.biopha.2023.115255"},{"key":"ref92","doi-asserted-by":"publisher","unstructured":"Wang S, Chen Y, Wu C, Wang Y, Lin W, Bu R. Trehalose Alleviates Myocardial Ischemia\/Reperfusion Injury by Inhibiting NLRP3-Mediated Pyroptosis. Applied Biochemistry and Biotechnology. 2024; 196: 1194\u20131210.","DOI":"10.1007\/s12010-023-04613-8"},{"key":"ref93","doi-asserted-by":"publisher","unstructured":"Tian K, Song L, Liu L, Lai T, Liu W. Rutin Protects Myocardial Ischemia-Reperfusion Injury via the NF-\u03baB\/NLRP3\/Pyroptosis Pathway. ACS Omega. 2025; 10: 21777\u201321785.","DOI":"10.1021\/acsomega.5c01408"},{"key":"ref94","doi-asserted-by":"publisher","unstructured":"Xu XN, Jiang Y, Yan LY, Yin SY, Wang YH, Wang SB, et al. Aesculin suppresses the NLRP3 inflammasome-mediated pyroptosis via the Akt\/GSK3\u03b2\/NF-\u03baB pathway to mitigate myocardial ischemia\/reperfusion injury. Phytomedicine : International Journal of Phytotherapy and Phytopharmacology. 2021; 92: 153687.","DOI":"10.1016\/j.phymed.2021.153687"},{"key":"ref95","doi-asserted-by":"publisher","unstructured":"Chai X, Liang Z, Zhang J, Ding J, Zhang Q, Lv S, et al. Chlorogenic acid protects against myocardial ischemia-reperfusion injury in mice by inhibiting Lnc Neat1\/NLRP3 inflammasome-mediated pyroptosis. Scientific Reports. 2023; 13: 17803.","DOI":"10.1038\/s41598-023-45017-2"},{"key":"ref96","doi-asserted-by":"publisher","unstructured":"Lin J, Lai X, Fan X, Ye B, Zhong L, Zhang Y, et al. Oridonin Protects against Myocardial Ischemia-Reperfusion Injury by Inhibiting GSDMD-Mediated Pyroptosis. Genes. 2022; 13: 2133.","DOI":"10.3390\/genes13112133"},{"key":"ref97","doi-asserted-by":"publisher","unstructured":"Chen X, Lin S, Dai S, Han J, Shan P, Wang W, et al. Trimetazidine affects pyroptosis by targeting GSDMD in myocardial ischemia\/reperfusion injury. Inflammation Research. 2022; 71: 227\u2013241.","DOI":"10.1007\/s00011-021-01530-6"},{"key":"ref98","doi-asserted-by":"publisher","unstructured":"Li Y, Wang X, Meng X, Xia C, Yang C, Wang J, et al. Aerobic exercise inhibits GSDME-dependent myocardial cell pyroptosis to protect ischemia-reperfusion injury. Molecular Medicine (Cambridge, Mass.). 2024; 30: 273.","DOI":"10.1186\/s10020-024-01048-7"},{"key":"ref99","doi-asserted-by":"publisher","unstructured":"Lu Y, Chen K, Zhao W, Hua Y, Bao S, Zhang J, et al. Magnetic vagus nerve stimulation alleviates myocardial ischemia-reperfusion injury by the inhibition of pyroptosis through the M2AChR\/OGDHL\/ROS axis in rats. Journal of Nanobiotechnology. 2023; 21: 421.","DOI":"10.1186\/s12951-023-02189-3"},{"key":"ref100","doi-asserted-by":"publisher","unstructured":"Marunouchi T, Kyono M, Kikuchi N, Tanonaka K. Gemfibrozil mitigates caspase-11-driven myocardial pyroptosis in ischemia\/reperfusion injury in mice. Journal of Molecular and Cellular Cardiology Plus. 2025; 12: 100292.","DOI":"10.1016\/j.jmccpl.2025.100292"},{"key":"ref101","doi-asserted-by":"publisher","unstructured":"Leng L, Li P, Liu R, Francis OB, Song S, Sui Y, et al. The main active components of Prunella vulgaris L. alleviate myocardial ischemia-reperfusion injury by inhibiting oxidative stress and ferroptosis via the NRF2\/GPX4 pathway. Journal of Ethnopharmacology. 2025; 345: 119630.","DOI":"10.1016\/j.jep.2025.119630"},{"key":"ref102","doi-asserted-by":"publisher","unstructured":"Zhang X, He J, Xu Z, Yang Y. Naringin regulates the cGAS-STING pathway to improve mitochondrial dysfunction and ferroptosis after myocardial ischemia-reperfusion injury. Cytotechnology. 2025; 77: 103.","DOI":"10.1007\/s10616-025-00762-2"},{"key":"ref103","doi-asserted-by":"publisher","unstructured":"Liang Y, Zhao L, Zhang X, Liu S, Lu P, Wang J, et al. Lactobacillus ameliorates myocardial ischemia reperfusion injury by attenuating apoptosis, inflammation, oxidative stress, and ferroptosis. BMC Medicine. 2025; 23: 377.","DOI":"10.1186\/s12916-025-04203-x"}],"container-title":["Reviews in Cardiovascular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.imrpress.com\/journal\/RCM\/27\/7\/10.31083\/RCM50196","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T10:33:05Z","timestamp":1785407585000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.imrpress.com\/journal\/RCM\/27\/7\/10.31083\/RCM50196"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,14]]},"references-count":103,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026]]}},"alternative-id":["S1530-6550(26)03253-0"],"URL":"https:\/\/doi.org\/10.31083\/rcm50196","relation":{},"ISSN":["1530-6550","2153-8174"],"issn-type":[{"value":"1530-6550","type":"print"},{"value":"2153-8174","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,14]]},"article-number":"50196"}}